General MedicationsIMPLANTATIONGeneric
PROBUPHINE
BUPRENORPHINE HYDROCHLORIDE
Standard Dose
EQ 80MG BASE/IMPLANT
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview PROBUPHINE is listed in Drugs@FDA under application 204442 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient BUPRENORPHINE HYDROCHLORIDE Form and strength IMPLANT;IMPLANTATION - EQ 80MG BASE/IMPLANT Sponsor REACX PHARMS Submission history Latest submission status date: 2025-12-22 00:00:00.
Structured Monograph
Clinical summary
Approval overview PROBUPHINE is listed in Drugs@FDA under application 204442 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient BUPRENORPHINE HYDROCHLORIDE Form and strength IMPLANT;IMPLANTATION - EQ 80MG BASE/IMPLANT Sponsor REACX PHARMS Submission history Latest submission status date: 2025-12-22 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.